Table 2. Clinical characteristics of 568 patients with no or mild symptoms of coronavirus disease isolated 3 in community treatment centers, South Korea*.
| Characteristics |
Total, n = 568 |
Gimje, n = 169 |
Gyeongju, n = 289 |
Jecheon, n = 110 |
|---|---|---|---|---|
| Current statistics | ||||
| In isolation in community treatment center | 356 (62.7) | 131 (77.5) | 147 (50.9) | 78 (70.9) |
| Discharged with recovery | 200 (35.2) | 33 (19.5) | 137 (47.4) | 30 (27.3) |
| Transferred to a hospital |
12 (2.1) |
5 (3.0) |
5 (1.7) |
2 (1.8) |
| Sex | ||||
| F | 367 (64.6) | 101 (59.8) | 185 (64.0)2 | 81 (73.6) |
| M | 201 (35.4) | 68 (40.2) | 104 (36.0) | 29 (26.4) |
| Age, mean ±SD |
36.0 ± 15.0 |
33.4 ± 14.6 |
37.8 ± 14.5 |
35.0 ± 16.2 |
| Underlying conditions† |
36 (6.3) |
3 (1.8) |
26 (9.0) |
7 (6.4) |
| COVID-19 symptoms over the course of disease‡ | ||||
| N | 430 (75.7) | 115 (68.0) | 238 (82.4) | 77 (70.0) |
| Y |
138 (24.3) |
54 (32.0) |
51 (17.6) |
33 (30.0) |
| rRT-PCR tests per patient, mean ±SD |
2.83 ± 1.17 |
2.82 ± 1.04 |
2.73 ± 1.26 |
3.11 ± 1.09 |
| rRT-PCR tests needed before discharge criteria met, % patients§ | ||||
| 2 | 33.3 (189/568) | 23.7 (40/169) | 43.3 (125/289) | 21.8 (24/110) |
| 3 | 12.4 (47/379) | 17.8 (23/129) | 11.6 (19/164) | 5.8 (5/86) |
| 4 |
14.5 (48/332) |
7.5 (8/106) |
19.3 (28/145) |
14.8 (12/81) |
| rRT-PCR results | ||||
| Follow-up 1 | N = 558 | N = 166 | N = 284 | N = 108 |
| Negative | 307 (55.0) | 65 (39.2) | 188 (66.2) | 54 (50.0) |
| Positive | 143 (25.6) | 56 (33.7) | 58 (20.4) | 29 (26.9) |
| Inconclusive | 108 (19.4) | 45 (27.1) | 38 (13.4) | 25 (23.1) |
| Follow-up 2 | N = 539 | N = 164 | N = 267 | N = 108 |
| Negative | 295 (54.7) | 85 (51.8) | 172 (64.4) | 38 (35.2) |
| Positive | 119 (22.1) | 32 (19.5) | 50 (18.7) | 37 (34.3) |
| Inconclusive | 125 (23.2) | 47 (28.7) | 45 (16.9) | 33 (30.5) |
| Follow-up 3 | N = 292 | N = 96 | N = 123 | N = 73 |
| Negative | 14 (49.0) | 42 (43.8) | 72 (58.5) | 29 (39.7) |
| Positive | 53 (18.1) | 20 (20.8) | 16 (13.0) | 17 (23.3) |
| Inconclusive | 96 (32.9) | 34 (35.4) | 35 (28.5) | 27 (37.0) |
| Follow-up 4 | N = 152 | N = 33 | N = 74 | N = 45 |
| Negative | 81 (53.3) | 20 (60.6) | 39 (52.7) | 22 (48.9) |
| Positive | 202 (13.2) | 1 (3.0) | 12 (16.2) | 7 (15.5) |
| Inconclusive |
51 (33.5) |
12 (36.4) |
23 (31.1) |
16 (35.6) |
| Days in isolation, mean ±SD¶ | ||||
| All patients, 2020 Mar 23 | 19.6 ± 5.8 | 17.9 ± 5.2 | 21.3 ± 5.9 | 17.9 ± 5.5 |
| Patients currently admitted | 22.2 ± 5.0 | 19.1 ± 5.0 | 25.9 ± 3.4 | 20.7 ± 2.6 |
| Patients discharged with recovery | 15.6 ± 4.0 | 14.5 ± 3.7 | 16.7 ± 3.6 | 11.6 ± 3.5 |
| Patients transferred to a hospital | 9.6 ± 5.2 | 11.0 ± 3.7 | 11.4 ± 4.4 | 1.5 ± 2.1 |
*As of March 23, 2020. Values are no. (%) except where otherwise indicated. CTC, community treatment center; rRT-PCR, real-time reverse transcription PCR. †Includes any chronic disease requiring medication, such as diabetes or hypertension. ‡Includes fever, dyspnea, cough, sputum, nasal congestion, decreased sense of smell or taste, sore throat, or diarrhea. §Two negative results >24 h apart are required before patient discharge. ¶Includes the period of self-isolation at home before being admitted at the center.